
Antimicrobial Prophylaxis in Pregnancy - Phase 2: Understanding Baseline Data
Women’s & Reproductive Health (Obstetrics & Gynecology), Infectious Diseases & Immunology
2023-02-01 – 2025-03-31
Antibiotic prophylaxis during pregnancy is critical for preventing serious complications, including early-onset neonatal Group B Streptococcus (GBS) disease and post-cesarean surgical site infections. Although penicillin remains the preferred first-line agent—and cefazolin is a safe alternative—many patients with a documented penicillin allergy are prescribed less effective second-line antibiotics. This is often driven by outdated assumptions or inaccurate allergy labels, despite strong evidence that the vast majority of reported penicillin allergies are not clinically significant.
This multi-phase project aims to better understand current prescribing patterns and the factors contributing to suboptimal antibiotic use in pregnancy. Insights from this work will inform targeted knowledge translation and intervention strategies to support more appropriate, evidence-based antimicrobial use and improve outcomes for both mothers and infants. The project is led by PLP Medical Director Dr. Eliana Castillo, in collaboration with Dr. Lynora Saxinger and the AHS Antimicrobial Stewardship group.
Building off of the first phase of this project, we examined Alberta’s obstetrical antimicrobial prophylaxis practices to identify gaps and opportunities for clinical improvement. This used healthcare administrative data to establish a baseline of current antimicrobial prophylaxis practices for early-onset neonatal Group B streptococcus (GBS) disease and surgical site infection (SSI) prevention during labor and delivery. The analysis of obstetrical information on patients who delivered in Alberta hospital sites between November 1, 2022 and May 31, 2023 showed that the majority of patients received appropriate antimicrobial prophylaxis for GBS and SSI prevention. However, suboptimal second-line antibiotics persisted in some penicillin allergy cases, despite cefazolin being the most common alternative.
Considering the persistence of inappropriate penicillin allergy labelling and administration of suboptimal antimicrobial prophylaxis, there are opportunities for quality improvement (QI) initiatives to promote validation of allergy status and address the use of sub-optimal antibiotics for penicillin allergy. This QI work will be incorporated into the broader KT work that is on-going for our program of work in optimizing antimicrobial use in Alberta. A report summarizing this work has been prepared and an academic manuscript will support broader dissemination of the findings.
PLP Publication Related to this Work:
Ofosu NN, Tate J, Hruczkowski C, Feuffel C, Collier L, Mathe N, Bruce M, Campbell-Scherer D, Castillo E. Antimicrobial prophylaxis practices for obstetrical infection prevention in Alberta: a multi-method study. Journal of Obstetrics and Gynaecology Canada. 2025; 48(1):1-10. https://doi.org/10.1016/j.jogc.2025.103173.